Stock Events

PTC Therapeutics (BH3.F) Q1 2024 Earnings

29FebConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-2.43
-1.66
-0.9
-0.13

Details

Expected EPS
-0.12955460000000002
Actual EPS
-1.9063034
Surprise EPS
-1.78
Surprise Percent
+1,371.43%

Description

PTC Therapeutics (BH3.F) has reported earnings of -1.9063034 per share for Q1 2024.

0 Comments

Share your thoughts